Extended and Minor Blood-Group Antigen Systems

Beyond ABO and Rh, red cells carry antigens belonging to many other blood-group systems, including Kell, Duffy, Kidd, and MNS. Although usually called minor, several of these systems can provoke clinically significant antibodies, and extended phenotyping or genotyping is used to match donors and recipients more precisely.

Definition

Extended and minor blood-group antigen systems are the red-cell antigen systems other than ABO and Rh, defined by the International Society of Blood Transfusion, whose antigens can stimulate alloantibodies of variable clinical significance.

Scope

This topic surveys the principal non-ABO, non-Rh blood-group systems and their clinical relevance, and introduces extended phenotyping and red-cell genotyping. It is a reference orientation to these systems rather than a guide to selecting units for individual patients.

Core questions

• Which blood-group systems lie beyond ABO and Rh, and how are they defined?
• Which minor-system antibodies are clinically significant?
• When is extended red-cell phenotyping or genotyping used?
• How do these systems relate to alloimmunization in transfusion and pregnancy?

Key concepts

• ISBT blood-group system classification
• Kell system (including K antigen)
• Duffy system (Fya, Fyb)
• Kidd system (Jka, Jkb)
• MNS system
• Extended phenotyping
• Red-cell genotyping

Mechanisms

Each blood-group system is defined by antigens carried on a particular membrane protein or carbohydrate and is recognised by the International Society of Blood Transfusion when its genetic basis is established. Antibodies to minor-system antigens, like other red-cell antibodies, generally arise after exposure through transfusion or pregnancy; their clinical significance depends on whether they react at body temperature and bind IgG that can shorten red-cell survival. The Kidd antibodies are notable for falling to undetectable levels and causing delayed haemolytic reactions on re-exposure, while Kell and Duffy antibodies are recognised causes of haemolytic disease of the fetus and newborn and of transfusion reactions. Extended phenotyping by serology, or genotyping by DNA analysis, identifies a person's antigen profile so that antigen-matched units can be provided, which is particularly valuable in chronically transfused patients.

Clinical relevance

Knowledge of minor blood-group systems supports prevention of haemolytic reactions and of haemolytic disease of the fetus and newborn, especially through antigen-matched transfusion in vulnerable groups. This entry describes the systems and their significance in principle and does not prescribe matching policy for individual patients.

Epidemiology

Antigen frequencies in these systems vary substantially between populations, which affects the probability of finding compatible units and the alloimmunization risk when donor and recipient ancestries differ. This is clinically important in chronically transfused patients such as those with sickle cell disease.

Evidence & guidelines

The blood-group systems are catalogued and updated by the International Society of Blood Transfusion and described in reference texts such as Daniels' Human Blood Groups; their transfusion implications are reviewed in the haematology literature.

History

After ABO and Rh, the MNS, Kell, Duffy, and Kidd systems were described in the 1940s and 1950s as new antibodies were detected and their antigens characterised. The number of recognised systems has since grown to several dozen as the molecular basis of red-cell antigens has been defined, and the International Society of Blood Transfusion maintains the formal classification.

Key figures

• Geoff Daniels
• Marion Reid
• Ruth Sanger
• Robert Race

Seminal works

• daniels-2013
• mollison-2014
• tormey-2019

Frequently asked questions

Are minor blood-group antigens clinically important?

They can be: although less prominent than ABO and Rh, antibodies in systems such as Kell, Duffy, and Kidd can cause haemolytic transfusion reactions and haemolytic disease of the fetus and newborn.

What is extended red-cell phenotyping?

Extended phenotyping determines a person's antigens across multiple blood-group systems, by serology or by genotyping, so that antigen-matched units can be selected, which is especially useful for patients who are transfused frequently.